Naltrexone And Bupropion
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1496
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| NB32 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 28 | n/r | n/r |